National action plan on antimicrobial resistance: An evaluation of implementation in the World Health Organization Africa region.
AMR-action-plan
Antimicrobial-resistance
WHOAFRO
workshop
Journal
Journal of public health in Africa
ISSN: 2038-9922
Titre abrégé: J Public Health Afr
Pays: Italy
ID NLM: 101586943
Informations de publication
Date de publication:
26 Jul 2022
26 Jul 2022
Historique:
received:
02
08
2021
accepted:
23
04
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
3
9
2022
Statut:
epublish
Résumé
In line with global instruments, within the last five years, two-thirds of all countries in the WHO Africa Region (WHO AFR) have developed a National Action Plan (NAP) on Antimicrobial Resistance (AMR). We sought to evaluate progress made across the countries implementing NAP for effective response to AMR. A semi-structured survey tool was administered to obtain information from national focal persons on the implementation of strategic elements of NAP on AMR. This was followed by a Lessons Learnt Workshop in June 2019 at Douala, Cameroon, where focal persons made presentations on the country's progress. Later, a desktop review of the LLW report and other key documents was conducted. Countries in WHO AFR that have set up a national surveillance system and are enrolled into the WHO global antimicrobial resistance surveillance system have progressively increased to 30 (of 47 countries), of which 15 are already submitting surveillance data. Of the 20 countries at the Lessons Learnt Workshop, 14 have infection prevention and control (IPC) policies and functional healthcare facility IPC programs, 15 participate in the commemoration of the annual world hand hygiene days. Although almost all countries surveyed have national standard treatment guidelines, only five have incorporated the WHO AWaRe classification into the national essential medicines list. Fourteen of 20 countries have established an active/functional national secretariat/coordinating center for AMR. Discernible progress is being made on the implementation of NAP in WHO AFR region. Gaps identified in the strategic elements of action plans need to be filled for effective AMR control.
Identifiants
pubmed: 36051526
doi: 10.4081/jphia.2022.2000
pmc: PMC9425955
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2000Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
©Copyright: the Author(s).
Déclaration de conflit d'intérêts
Conflict of interest: None of the funders had any roles in the design, data collection, analysis and writing of the report. Authors declare there are no financial or personal relationships that may have inappropriately influenced them in writing the manuscript.
Références
JAC Antimicrob Resist. 2019 Nov 12;1(3):dlz072
pubmed: 34222945
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
Lancet Infect Dis. 2018 Feb;18(2):e33-e44
pubmed: 29033034
Bull World Health Organ. 2011 Oct 1;89(10):757-65
pubmed: 22084514
J Antimicrob Chemother. 2014 Sep;69(9):2337-53
pubmed: 24879668
J Law Med Ethics. 2015 Summer;43 Suppl 3:17-21
pubmed: 26243238
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
Afr J Lab Med. 2018 Dec 06;7(2):796
pubmed: 30568902
J Antimicrob Chemother. 2020 Mar 1;75(3):492-507
pubmed: 31742611